Jalra Trio Tablet is a combination medication used to manage type 2 diabetes mellitus in adults. It contains three active ingredients:

• Vildagliptin (100mg): A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and decreases glucagon production, leading to improved blood glucose control.

  drugs.com

• Dapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that prevents glucose reabsorption in the kidneys, promoting its excretion through urine.

  netmeds.com

• Metformin (500mg): A biguanide that decreases hepatic glucose production and increases insulin sensitivity, aiding in blood sugar regulation.

  netmeds.com

Usage:

This medication is prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The specific dosage and duration should be determined by a healthcare professional based on individual patient needs.

Possible Side Effects:

Patients may experience side effects such as:

• Hypoglycemia: Low blood sugar levels, especially when combined with other antidiabetic agents.

• Urinary tract infections: Increased risk due to the presence of glucose in urine.

• Gastrointestinal disturbances: Including nausea, diarrhea, or abdominal discomfort.

• Weight loss: Potential reduction in body weight.

• Increased urination: Due to the diuretic effect of dapagliflozin.

It's essential to monitor for these side effects and consult a healthcare provider if they persist or worsen.

Precautions:

• Renal Impairment: Not recommended for patients with moderate to severe kidney problems.

• Hepatic Impairment: Use with caution in patients with liver disorders.

• Elderly Patients: Dose adjustments may be necessary due to potential renal function decline.

Always consult a healthcare professional before starting or adjusting the dosage of this medication to ensure its safety and efficacy.